- Global Pharma News & Resources

Global PTCA Balloon Catheters Devices Pipeline Assessment 2020: Stage of Development, Segment, Territory, Regulatory Path, Estimated Approval Date, Ongoing Clinical Trials -

DUBLIN--(BUSINESS WIRE)--The "PTCA Balloon Catheters - Medical Devices Pipeline Assessment, 2020" report has been added to's offering.

"PTCA Balloon Catheters-Medical Devices Pipeline Assessment, 2020" Percutaneous Transluminal Coronary Angioplasty (PTCA) is a procedure that helps restore blood flow to a blocked coronary artery without the requirement of open heart surgery.


  • Extensive coverage of the PTCA Balloon Catheters under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of PTCA Balloon Catheters and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of PTCA Balloon Catheters under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Key Topics Covered:

1 Table of Contents

2 Introduction

2.1 PTCA Balloon Catheters Overview

3 Products under Development

3.1 PTCA Balloon Catheters-Pipeline Products by Stage of Development

3.2 PTCA Balloon Catheters-Pipeline Products by Segment

3.3 PTCA Balloon Catheters-Pipeline Products by Territory

3.4 PTCA Balloon Catheters-Pipeline Products by Regulatory Path

3.5 PTCA Balloon Catheters-Pipeline Products by Estimated Approval Date

3.6 PTCA Balloon Catheters-Ongoing Clinical Trials

4 PTCA Balloon Catheters-Pipeline Products under Development by Companies

4.1 PTCA Balloon Catheters Companies-Pipeline Products by Stage of Development

4.2 PTCA Balloon Catheters-Pipeline Products by Stage of Development

5 PTCA Balloon Catheters Companies and Product Overview

6 PTCA Balloon Catheters-Recent Developments

7 Appendix

Companies Mentioned

  • 3DT Holdings LLC
  • Aachen Resonance GmbH
  • Acrostak (Schweiz) AG
  • AlviMedica Medical Technologies Inc
  • Andramed GmbH
  • Atrium Medical Corp
  • B. Braun Interventional Systems Inc
  • Bolton Medical Inc
  • Boston Scientific Corp
  • BrosMed Medical Co., Ltd
  • Caliber Therapeutics Inc
  • CardioNiTi Ltd.
  • Concept Medical Inc
  • Cordis Corp
  • CorNova Inc
  • Innovia LLC
  • iVascular SLU
  • Lifetech Scientific (Shenzhen) Co Ltd
  • M.A. Med Alliance SA
  • Medix Innovators Inc.
  • Medtronic Plc
  • Meril Life Sciences Pvt Ltd
  • MicroPort Scientific Corp
  • Natec Medical Ltd
  • OrbusNeich
  • Orchestra BioMed Inc
  • QT Vascular Ltd
  • QualiMed Innovative Medizinprodukte GmbH
  • Sahajanand Medical Technologies Pvt Ltd
  • 3SIS Medical AG
  • Spectranetics Corp
  • Transit Scientific LLC
  • Vascular Nanotransfer Technologies
  • VasoTech Inc.

For more information about this report visit

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Editor Details

  • Company:
    • Businesswire
Last Updated: 15-Jan-2021